Previous 10 | Next 10 |
2024-07-02 11:20:47 ET Summary This article will outline nine steps I use to identify the most promising pharmaceutical companies and avoid investment pitfalls. In addition, each of the nine steps will provide examples of various factors and how they influence the assessment of th...
2024-07-02 09:17:30 ET More on Eli Lilly 5 Reasons Eli Lilly Just Keeps Rising Eli Lilly: Throwing Its Weight Around - But, For How Long? (Technical Analysis) Eli Lilly: The Party Is Probably Nearing The End Lilly in deal with Radionetics Oncology on radiopha...
2024-06-30 09:00:00 ET Summary VRNA received FDA approval for ensifentrine (Ohtuvayre) for the maintenance treatment of COPD on June 26. SNY/REGN's Dupixent represents a potential competitor. As do other drugs in development from SNY/REGN and GSK. Verona has the potential for ...
2024-06-29 15:44:55 ET More on Eli Lilly, Novo Nordisk, etc. Novo Nordisk Breaks Out To An All-Time High On China Approval Of Wegovy Eli Lilly: Throwing Its Weight Around - But, For How Long? (Technical Analysis) Eli Lilly: The Party Is Probably Nearing The End ...
2024-06-27 08:11:40 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Vigil Neuroscience (NASDAQ: VIGL ) stock is soaring higher on Thursday after the clinical-stage biotechnology company revealed a $40 million strategic investment from Sanofi ...
2024-06-27 07:04:12 ET More on Vigil Neuroscience Biggest stock movers today: BB, MU, and more Augustine Therapeutics raises €17M in series A first closing Seeking Alpha’s Quant Rating on Vigil Neuroscience Historical earnings data for Vigil Neu...
2024-06-27 05:19:29 ET More on related stocks: Micron Technology, Inc. (MU) Q3 2024 Earnings Call Transcript BlackBerry Limited (BB) Q1 2025 Earnings Call Transcript BlackBerry Stock: 4 Considerations Ahead Of Its Q1 2025 Earnings International Paper sinks af...
2024-06-25 14:14:25 ET More on Sanofi Sanofi's Immunology Business Is Doing A Lot Of Heavy Lifting Sanofi: A Leader In Life-Saving Vaccines And Treatments Sanofi Q1: Wait And See For Now (Downgrade) Sanofi a beneficiary of Alnylam's data on heart drug Amvuttr...
2024-06-25 12:31:58 ET More on CSL CSL Seqirus to provide more than 40M bird flu vaccine doses to Europe Travere, CSL win conditional nod for kidney disease therapy in EU Seeking Alpha’s Quant Rating on CSL Historical earnings data for CSL Divi...
2024-06-25 11:08:09 ET Eli Lilly and Company ( NYSE: LLY ) said on Tuesday that it is collaborating with Microsoft ( MSFT ) backed-OpenAI that will help leverage generative AI to invent novel antimicrobials to treat drug-resistant pathogens.... Read the full article on See...
News, Short Squeeze, Breakout and More Instantly...
Fluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza Canada NewsWire TORONTO , July 26, 2024 /CNW/ - The National Advisory Committee on Immunization's (NACI) annual Statement...
Ontario Ministry of Health Announces a Universal Public Program with Beyfortus® this RSV Season Canada NewsWire TORONTO , July 25, 2024 /CNW/ - The Ontario Ministry of Health has announced a universal public program with Beyfortus ® (nirsevimab...